4//SEC Filing
Friedl-Naderer Johanna 4
Accession 0000950170-25-038750
CIK 0001818794other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:13 PM ET
Size
5.1 KB
Accession
0000950170-25-038750
Insider Transaction Report
Form 4
Friedl-Naderer Johanna
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-03-13$12.12/sh−143$1,733→ 96,057 total
Footnotes (2)
- [F1]Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.
- [F2]Includes 93,838 unvested RSUs.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001915598
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 4:13 PM ET
- Size
- 5.1 KB